results of this MD Anderson study were recently published in Cancers and indicate the relevance of enumeration of Circulating Tumor Cells (CTCs) with the .
Introducing Sapphire FL Azure Biosystems announces the release of the Sapphire FL Biomolecular Imager, a ground-breaking new imaging system which introduces a patent-pending, fully customisable, user-interchangeable laser-filter module mechanism that allows you to either choose the laser-filter pairs best suited for your research, or create your own laser-filter pairs. Click to read more.
Manhattan Scientifics Inc. , which provided the initial funding &, currently owns more than 50 million shares of Imagion Biosystems Ltd. celebrates Imagion s remarkable progress in early cancer. | May 31, 2023
By Chris Wack T2 Biosystems said Tuesday that it has submitted a 510 premarket notification to the Food and Drug Administration for its T2Biothreat panel. The FDA submission follows the. | May 23, 2023
LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) T2 Biosystems, Inc. (NASDAQ:TTOO) (the "Company"), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today